Durukan, Ö. Et Al. 2017. Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines. 3rd International Symposium on Euroasian Biodiversity , (Minsk, Belarus), 323.

Durukan, Ö., Evin, E., Arslan, Ş., & Adalı, O., (2017). Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines . 3rd International Symposium on Euroasian Biodiversity (pp.323). Minsk, Belarus

Durukan, Özlem Et Al. "Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines," 3rd International Symposium on Euroasian Biodiversity, Minsk, Belarus, 2017

Durukan, Özlem Et Al. "Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines." 3rd International Symposium on Euroasian Biodiversity , Minsk, Belarus, pp.323, 2017

Durukan, Ö. Et Al. (2017) . "Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines." 3rd International Symposium on Euroasian Biodiversity , Minsk, Belarus, p.323.

@conferencepaper{conferencepaper, author={Özlem Durukan Et Al. }, title={Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines}, congress name={3rd International Symposium on Euroasian Biodiversity}, city={Minsk}, country={Belarus}, year={2017}, pages={323} }